Mesoblast (MESO) Cash from Financing Activities (2016 - 2023)

Mesoblast (MESO) posted Cash from Financing Activities of $38.8 million for Q2 2023, up 1625.27% sequentially from -$2.5 million in Q1 2023, and up 1848.96% YoY from $2.0 million in Q2 2022.

Mesoblast (MESO) Cash from Financing Activities (2016 - 2023) Analysis & Trends

Mesoblast has reported Cash from Financing Activities for 8 years, with the latest figure at $38.8 million in Q2 2023.

  • Quarterly Cash from Financing Activities rose 1848.96% year-over-year to $38.8 million in Q2 2023, while the trailing twelve-month figure through Jun 2023 was $74.5 million (up 854.83% YoY) and the FY2025 annual result came in at $147.3 million, up 266.03% from the prior year.
  • Cash from Financing Activities grew to $38.8 million in Q2 2023 per MESO's latest filing, from -$2.5 million in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $106.4 million in Q1 2021 and troughed at -$2.9 million in Q4 2021.
  • A 5-year average of $17.8 million and a median of -$50500.0 in 2019 frame the typical range for Cash from Financing Activities.
  • The sharpest annual moves came in 2020 and 2021: Cash from Financing Activities jumped 251518.18% in 2020, then tumbled 294.22% in 2021.
  • Over 5 years, Cash from Financing Activities stood at $48.2 million in 2019, then sank by 101.54% to -$744000.0 in 2020, then sank by 294.22% to -$2.9 million in 2021, then jumped by 31.4% to -$2.0 million in 2022, then soared by 2026.29% to $38.8 million in 2023.
  • According to Business Quant data, Cash from Financing Activities over the past three periods registered $38.8 million, -$2.5 million, and -$2.0 million for Q2 2023, Q1 2023, and Q4 2022 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -426.70 Mn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn -1.22 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - 2.42 Bn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn -6.05 Mn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -207,909.22
7 Royalty Pharma 33.72 Bn 35.84 Bn - -273.15 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 36.24 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 27.18 Mn
10 Mesoblast 2.01 Bn 1.87 Bn - -

Historic Data

Download Data
DateValue
Jun 30, 2023 38.76 Mn
Jun 30, 2023 38.76 Mn
Mar 31, 2023 -2.54 Mn
Mar 31, 2023 -2.54 Mn
Dec 31, 2022 -2.01 Mn
Dec 31, 2022 -2.01 Mn
Sep 30, 2022 40.30 Mn
Sep 30, 2022 40.30 Mn
Jun 30, 2022 -2.22 Mn
Jun 30, 2022 -2.22 Mn
Mar 31, 2022 -2.57 Mn
Mar 31, 2022 -2.57 Mn
Dec 31, 2021 -2.93 Mn
Dec 31, 2021 -2.93 Mn
Sep 30, 2021 -2.15 Mn
Sep 30, 2021 -2.15 Mn
Jun 30, 2021 -2.24 Mn
Jun 30, 2021 -2.24 Mn
Mar 31, 2021 106.36 Mn
Mar 31, 2021 106.36 Mn